Linde plc (LIN):企業の財務・戦略的SWOT分析

◆英語タイトル:Linde plc (LIN) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDCH3434944FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:58
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:Chemicals
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥32,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥48,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Linde plc (LIN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Linde plc (Linde) is an industrial gas and engineering company. It supplies industrial, process, and specialty gases. The company’s products include atmospheric gases such as oxygen, nitrogen and argon; and process gases including carbon dioxide, helium, hydrogen, electronic gases and acetylene. Linde also designs, engineers, and builds equipment’s that produce gases for internal use and offers a wide range of gas production and processing services. It serves numerous industries including healthcare, petroleum refining, manufacturing, food, beverage carbonation, fiber-optics, steel making, aerospace, chemicals, electronics and water treatment. It operates cryogenic air separation plants, hydrogen plants and carbon dioxide plants across APAC, EMEA and Americas. Linde is headquartered in Guildford, Surrey, the UK.

Linde plc Key Recent Developments

Apr 19,2021: ITM Power: Electrolyser sale to Linde for H2Pioneer in Austria
Apr 14,2021: Sasol to explore potential of cleaner aviation fuels with world class partners
Apr 12,2021: Linde Announces First Quarter 2021 Earnings and Conference Call Schedule
Apr 08,2021: Linde Engineering and AGR collaborate on a trendsetting green hydrogen project
Mar 24,2021: BASF, SABIC and Linde join forces to realize the world’s first electrically heated steam cracker furnace

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Linde plc – Key Facts
Linde plc – Key Employees
Linde plc – Key Employee Biographies
Linde plc – Major Products and Services
Linde plc – History
Linde plc – Company Statement
Linde plc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Linde plc – Business Description
Business Segment: Americas
Overview
Performance
Key Stats
Business Segment: APAC
Overview
Performance
Key Stats
Business Segment: EMEA
Overview
Performance
Key Stats
Business Segment: Engineering
Overview
Performance
Business Segment: Other
Overview
Performance
Geographical Segment: Australia
Performance
Geographical Segment: Brazil
Performance
Geographical Segment: China
Performance
Geographical Segment: Germany
Performance
Geographical Segment: Other – International
Performance
Geographical Segment: United Kingdom
Performance
Geographical Segment: United States
Performance
R&D Overview
Linde plc – Corporate Strategy
Linde plc – SWOT Analysis
SWOT Analysis – Overview
Linde plc – Strengths
Linde plc – Weaknesses
Linde plc – Opportunities
Linde plc – Threats
Linde plc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Linde plc, Recent Deals Summary
Section 4 – Company’s Recent Developments
Apr 19, 2021: ITM Power: Electrolyser sale to Linde for H2Pioneer in Austria
Apr 14, 2021: Sasol to explore potential of cleaner aviation fuels with world class partners
Apr 12, 2021: Linde Announces First Quarter 2021 Earnings and Conference Call Schedule
Apr 08, 2021: Linde Engineering and AGR collaborate on a trendsetting green hydrogen project
Mar 24, 2021: BASF, SABIC and Linde join forces to realize the world’s first electrically heated steam cracker furnace
Mar 08, 2021: Linde to supply world’s first hydrogen-powered ferry
Mar 04, 2021: Linde recognized by bloomberg as leader in gender equality
Mar 01, 2021: Linde recognized as one of the 2021 world’s most ethical companies
Mar 01, 2021: Linde recognized as one of 2021 world’s most ethical companies
Feb 22, 2021: Linde recognized by S&P Global in the sustainability yearbook 2021
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Linde plc, Key Facts
Linde plc, Key Employees
Linde plc, Key Employee Biographies
Linde plc, Major Products and Services
Linde plc, History
Linde plc, Subsidiaries
Linde plc, Key Competitors
Linde plc, Ratios based on current share price
Linde plc, Annual Ratios
Linde plc, Annual Ratios (Cont...1)
Linde plc, Annual Ratios (Cont...2)
Linde plc, Interim Ratios
Linde plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Linde plc (LIN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • iBio Inc (IBIO):企業の財務・戦略的SWOT分析
    Summary iBio Inc (iBio) is a biotechnology company that develops and manufactures plant made pharmaceutical products. The company provides products such as biotherapeutics and vaccines. It has its applications in ibiolaunch platform, which is a transformative technology for the production of monoclo …
  • Progress Software Corp (PRGS):企業の財務・戦略的SWOT分析
    Progress Software Corp (PRGS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • GN Hearing AS:医療機器:M&Aディール及び事業提携情報
    Summary GN Hearing AS (GN Hearing) formerly, GN ReSound A/S, a subsidiary of GN Store Nord A/S, is a medical equipment company that provides advanced hearing health care solutions. The company offers hearing aids, accessories and related products. It also supplies computerized audiology and hearing …
  • Chengdu Kanghong Pharmaceuticals Group Co Ltd (002773):製薬・医療:M&Aディール及び事業提携情報
    Summary Chengdu Kanghong Pharmaceuticals Group Co Ltd (Chengdu Kanghong Pharmaceuticals) is a pharmaceutical company that develops, manufactures and markets Chinese medicines, chemical drugs and biological products. The company offers products for the treatment of medical conditions related to centr …
  • China Aerospace Science and Industry Corp:戦略・SWOT・企業財務分析
    China Aerospace Science and Industry Corp - Strategy, SWOT and Corporate Finance Report Summary China Aerospace Science and Industry Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Digi International, Inc. (DGII):企業の財務・戦略的SWOT分析
    Digi International, Inc. (DGII) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Sun Pharmaceutical Industries Ltd (SUNPHARMA):医療機器:M&Aディール及び事業提携情報
    Summary Sun Pharmaceutical Industries Ltd (Sun Pharma) is a specialty pharmaceutical company, which offers a wide range of pharmaceutical formulations such as branded generics and generic pharmaceuticals. The company’s products find application in the treatment of various conditions related to psych …
  • Nathan’s Famous, Inc. (NATH):企業の財務・戦略的SWOT分析
    Nathan's Famous, Inc. (NATH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Orchid Pharma Ltd (ORCHIDPHAR):企業の財務・戦略的SWOT分析
    Summary Orchid Pharma Ltd (Orchid), formerly Orchid Chemicals & Pharmaceuticals Ltd is a pharmaceutical company that develops and manufactures pharmaceutical solutions such as formulations and API products. The company offers formulations such as cardiovascular products, neuropsychiatry products, an …
  • Calypso Biotech SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Calypso Biotech SA (Calypso) is a biopharmaceutical company that develops antibody therapies. The company provides pipeline products such as CALY-0001 and CALY-0002. Its CALY-0001 therapeutic antibody is used in the treatment of Crohn’s disease; and CALY-0002 a humanized monoclonal antibody …
  • GH Armor Systems Inc.:企業の戦略・SWOT・財務情報
    GH Armor Systems Inc. - Strategy, SWOT and Corporate Finance Report Summary GH Armor Systems Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Flexsteel Industries Inc (FLXS):企業の財務・戦略的SWOT分析
    Flexsteel Industries Inc (FLXS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • California Physicians’ Service:企業の戦略的SWOT分析
    California Physicians' Service - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Hang Lung Properties Limited:企業の戦略・SWOT・財務情報
    Hang Lung Properties Limited - Strategy, SWOT and Corporate Finance Report Summary Hang Lung Properties Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Ra Pharmaceuticals Inc (RARX):医療機器:M&Aディール及び事業提携情報
    Summary Ra Pharmaceuticals Inc (Ra Pharmaceuticals) is a clinical stage biopharmaceutical company that develops therapeutics for the treatment of diseases caused due to uncontrolled activation of the complement system. Ra Pharmaceuticals develops its pipeline products through its proprietary peptide …
  • Arrowhead Pharmaceuticals Inc (ARWR):企業の財務・戦略的SWOT分析
    Summary Arrowhead Pharmaceuticals Inc (Arrowhead), formerly known as Arrowhead Research Corp, is a pharmaceutical company. It develops and markets medicinal products including ARO-AAT, JNJ-3989, ARO-APOC3, ARO-ANG3, ARO-ENaC, ARO-HIF2, ARO-Lung2, ARO-HSD, ARO-HIF2, AMG 890, ARO-JNJ1, ARO-JNJ2 and AR …
  • Inpex Corp (1605):企業の財務・戦略的SWOT分析
    Inpex Corp (1605) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Oil India Ltd (OIL):企業の財務・戦略的SWOT分析
    Oil India Ltd (OIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Cell Therapy Catapult Ltd-医療機器分野:企業M&A・提携分析
    Summary Cell Therapy Catapult Ltd (Catapult) is a developer of cell and gene therapies. The company supports cell and gene therapy companies worldwide to translate early stage research into commercially sustainable and investable treatments. It offers non-clinical safety, clinical trials, regulation …
  • Grupo Financiero Galicia S.A. (GGAL3):企業の財務・戦略的SWOT分析
    Grupo Financiero Galicia S.A. (GGAL3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆